This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bristol-Myers Squibb Names Dinesh C. Paliwal To Board Of Directors

Stocks in this article: BMY

Bristol-Myers Squibb Company (NYSE: BMY) today announced that its Board of Directors has elected Dinesh C. Paliwal to the Board, effective July 1, 2013. Mr. Paliwal will serve as a member of the Committee on Directors and Corporate Governance.

Paliwal, 55, who was born and raised in India, is currently the chairman, president and chief executive officer of Harman International Industries, Inc., a leading provider of premium audio and infotainment systems for the automotive, consumer and professional markets, a position he has held since 2008. He served as Harman’s president and chief executive officer from 2007 to 2008. Prior to joining Harman, he spent 22 years with ABB Group, a leader in power and automation technologies with operations in approximately 100 countries, where he last held the dual role of president, Global Markets and Technologies of ABB Ltd. and chairman and chief executive officer of ABB North America. While at ABB, Paliwal lived and worked in China for several years where he also served for three years as economic advisor to the governor of Guangdong Province. Paliwal serves on the board of ADT Corporation (NYSE: ADT) and has previously served as the chairman of the U.S. National Foreign Trade Council.

“We are very excited to have Dinesh join our Board,” said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb. “He is an accomplished leader who has worked in senior positions in Asia, Europe and the United States. I am confident his insights gained from more than 30 years of broad international experience will be of great value to our company.”

James M. Cornelius, chairman of Bristol-Myers Squibb, added, “Dinesh is an individual with high integrity. He has an impressive track record for driving entrepreneurship and leading edge innovation as well as a sharp focus on growth. We are fortunate to have him join our Board.”

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs